Sarepta Therapeutics, Inc. (SRPT)
14.99
-0.12
(-0.79%)
USD |
NASDAQ |
Jun 11, 14:51
Sarepta Therapeutics Accounts Payable (Quarterly) : 70.38M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 70.38M |
| December 31, 2025 | 280.84M |
| September 30, 2025 | 94.02M |
| June 30, 2025 | 136.70M |
| March 31, 2025 | 156.10M |
| December 31, 2024 | 214.44M |
| September 30, 2024 | 118.77M |
| June 30, 2024 | 107.42M |
| March 31, 2024 | 91.54M |
| December 31, 2023 | 164.92M |
| September 30, 2023 | 87.95M |
| June 30, 2023 | 109.80M |
| March 31, 2023 | 106.71M |
| December 31, 2022 | 95.88M |
| September 30, 2022 | 118.46M |
| June 30, 2022 | 56.21M |
| March 31, 2022 | 54.01M |
| December 31, 2021 | 76.74M |
| September 30, 2021 | 44.16M |
| June 30, 2021 | 76.68M |
| March 31, 2021 | 76.65M |
| December 31, 2020 | 111.09M |
| September 30, 2020 | 74.53M |
| June 30, 2020 | 91.66M |
| March 31, 2020 | 26.60M |
| Date | Value |
|---|---|
| December 31, 2019 | 68.09M |
| September 30, 2019 | 81.95M |
| June 30, 2019 | 44.04M |
| March 31, 2019 | 26.50M |
| December 31, 2018 | 33.83M |
| September 30, 2018 | 20.41M |
| June 30, 2018 | 17.38M |
| March 31, 2018 | 17.38M |
| December 31, 2017 | 8.467M |
| September 30, 2017 | 5.317M |
| June 30, 2017 | 10.92M |
| March 31, 2017 | 27.45M |
| December 31, 2016 | 29.69M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 20.23M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 12.41M |
| September 30, 2014 | 0.967M |
| June 30, 2014 | 1.309M |
| March 31, 2014 | 7.721M |
| December 31, 2013 | 17.63M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 30.75M |
| Moderna, Inc. | 161.00M |
| Denali Therapeutics, Inc. | 40.38M |
| Twist Bioscience Corp. | 14.68M |
| Revolution Medicines, Inc. | 80.54M |